LONDON and MILAN, Nov. 03, 2025(AAVantgarde), a clinical-stage, biotechnology company pioneering therapies for inherited retinal diseases (IRDs), today announced the successful closing of a $141 milli ...
Oil palm is not merely an industrial crop—it is a living organism full of potential, hard work, and sensitivity, deserving care ...